Oxurion advies
WebApr 14, 2024 · Beurscodes, betekenis en hulp bij zoeken Europa AEX Euronext Amsterdam BRU Euronext Brussels PSE Euronext Paris LIS Euronext Lissabon CHX CBOE Europe, grote(re) EU aandelen WebNov 28, 2024 · Oxurion received transparency notification on November 28 from Negma Group Ltd. indicating that as of November 22, it held 39,577,246 shares of the then outstanding 168,949,714 shares, and therefore crossed above the 20% threshold by virtue of acquisition of voting securities. See Annex 2.
Oxurion advies
Did you know?
WebJun 30, 2024 · Oxurion is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and … Web22 hours ago · Oxurion NV Tom Graney Chief Executive Officer Tel: +32 16 75 13 10 " [email protected] Michael Dillen Chief Business Officer Tel: +32 16 75 13 10
WebApr 6, 2024 · 6.7%. 10% least volatile stocks in BE Market. 2.5%. Stable Share Price: OXUR is more volatile than 90% of Belgian stocks over the past 3 months, typically moving +/- 15% a week. Volatility Over Time: OXUR's weekly volatility has decreased from 47% to 15% over the past year, but is still higher than 75% of Belgian stocks. WebApr 13, 2024 · EUR. -5.56%. 31/03. Oxurion : Oproeping voor de jaarlijkse algemene vergadering van aandeelhouders (GAV) van 2 mei 2024. PU. 31/03. Oxurion : Bijzonder …
WebOxurion verhoogt kapitaal met 500.000 euro. Negma Group Investment heeft 200 converteerbare obligaties omgezet in aandelen Oxurion. Dit werd vanmorgen … WebNov 21, 2024 · Oxurion ended 2024 with €10 million in available cash, according to its annual report, and added to that total by raising another €10 million in a private placement that closed in March.
WebStock OXURION Common Stock BE0003846632 XBRU Euronext Brussels Live Euronext kurser, quotes, realtime prices, charts, grafieken, bedrijfsnieuws, AEX BEL Beurs OXURION …
WebApr 12, 2024 · Keukenrol schreef op 12 april 2024 09:15:. Zolang ze gebruik maken van de korting creëren ze waarde voor de aandeelhouders. Een daling van 4% op dit nieuws is puur, omdat het aandeel tencent met 4,5% daalde. clerk of court rutherfordton ncWebMay 24, 2024 · Oxurion’s THR-687 is of special interest as it employs a novel mechanism of action (MOA), as a selective pan-RGD (arginylglycylaspartic acid) integrin antagonist, to treat diabetic retinopathy and various other vision-threatening retinal pathologies such as DME. At the ARVO annual meeting, data was presented for THR-687’s preclinical study ... bluff view art districtWebMar 14, 2024 · Funding Program between Oxurion and Negma Ends Funding Program between Oxurion and Negma Ends Leuven, BELGIUM, Boston, MA, US – March 2, 2024 8:00 am CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in … clerk of court sacramento caWebApr 14, 2024 · Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to … clerk of court sacremento californiaWebOxurion is een Belgisch gevestigd bedrijf dat onderzoek voert naar geneesmiddelen voor oogaandoeningen. In 2006 kwam de firma tot leven als ‘ Thrombogenics ’, maar de geschiedenis loopt nog verder terug in de tijd. In 1991 startte Professor Désiré Collen (Leuven) het bedrijf ‘Thromb-X’, gespecialiseerd in behandelingen voor patiënten ... clerk of court sacramento countyWebNov 4, 2024 · Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in ... clerk of courts act illinoisWebOxurion should annonce intermediate results by the end of 2024 ,in few days so ... They might do international licences for their major asset the THR 149 for DME therapy . Huge Market worldwide revaluated recently about 10 billion $ . 2024 Stocking time ... bluff view art district jobs